SOAT1 and acquired polycythemia vera: Through this systems approach, we found that the JAK2V617F mutation led to the over-activation of JAK/STAT signaling and the effect of the mutation was different between PV and ET based on the different receptor kinetics, supporting the different mutation patterns clinically observed in the patients.